TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Igelösa Life Science AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
4,714
|
7,393
|
6,906 |
Financial expenses |
0
|
1
![]() |
1 |
Earnings before taxes |
584
|
1,012
|
926 |
EBITDA |
302
|
916
|
-1,441 |
Total assets |
23,630
|
22,903
|
25,195 |
Current assets |
9,945
|
9,159
|
10,095 |
Current liabilities |
1,377
|
1,192
|
2,404 |
Equity capital |
22,147
|
21,606
|
22,677 |
- share capital |
672
|
668
|
727 |
Employees (average) |
9
|
10
![]() |
10 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
93.7%
|
94.3%
|
90.0% |
Turnover per employee |
524
|
739
|
691 |
Profit as a percentage of turnover |
12.4%
|
13.7%
|
13.4% |
Return on assets (ROA) |
2.5%
|
4.4%
|
3.7% |
Current ratio |
722.2%
|
768.4%
|
419.9% |
Return on equity (ROE) |
2.6%
|
4.7%
|
4.1% |
Change turnover |
-2,716
|
1,046
|
-682 |
Change turnover % |
-37%
|
16%
|
-9% |
Chg. No. of employees |
-1
|
0
|
-3 |
Chg. No. of employees % |
-10%
|
0%
|
-23% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.